Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	protein localization to M-band	ANK2 OBSCN	1.27e-05	2	74	2	GO:0036309
GeneOntologyCellularComponent	cell-cell junction	AKAP6 ANK2 PKP3 OBSCN TJAP1 ILDR1 SPECC1L SCRIB EPB41L3 SAPCD2	4.80e-05	591	75	10	GO:0005911
GeneOntologyCellularComponent	cell-cell contact zone	AKAP6 ANK2 OBSCN SCRIB	3.65e-04	94	75	4	GO:0044291
GeneOntologyCellularComponent	Atg1/ULK1 kinase complex	TBC1D5 SMCR8	4.50e-04	9	75	2	GO:1990316
GeneOntologyCellularComponent	anchoring junction	AKAP6 ANK2 PPFIBP1 PKP3 OBSCN TJAP1 ILDR1 SPECC1L SCRIB EPB41L3 SAPCD2	6.88e-04	976	75	11	GO:0070161
Domain	RPEL	MYOCD MRTFA	3.12e-04	7	73	2	PS51073
Domain	RPEL	MYOCD MRTFA	3.12e-04	7	73	2	PF02755
Domain	RPEL	MYOCD MRTFA	3.12e-04	7	73	2	SM00707
Domain	RPEL_repeat	MYOCD MRTFA	3.12e-04	7	73	2	IPR004018
Domain	PDZ	FRMPD4 ARHGAP23 MYO18A SCRIB	2.26e-03	141	73	4	PF00595
Domain	PDZ	FRMPD4 ARHGAP23 MYO18A SCRIB	2.70e-03	148	73	4	SM00228
Domain	-	FRMPD4 ARHGAP23 MYO18A SCRIB	2.83e-03	150	73	4	2.30.42.10
Domain	PDZ	FRMPD4 ARHGAP23 MYO18A SCRIB	2.90e-03	151	73	4	PS50106
Domain	PDZ	FRMPD4 ARHGAP23 MYO18A SCRIB	2.97e-03	152	73	4	IPR001478
Domain	-	MYOCD MRTFA	3.02e-03	21	73	2	1.10.720.30
Domain	RHOD	DUSP6 CEP41	3.31e-03	22	73	2	SM00450
Domain	SAP	MYOCD MRTFA	3.31e-03	22	73	2	PF02037
Domain	SAP	MYOCD MRTFA	3.61e-03	23	73	2	SM00513
Domain	RHODANESE_3	DUSP6 CEP41	3.61e-03	23	73	2	PS50206
Domain	Rhodanese-like_dom	DUSP6 CEP41	3.93e-03	24	73	2	IPR001763
Domain	Rhodanese	DUSP6 CEP41	3.93e-03	24	73	2	PF00581
Domain	-	DUSP6 CEP41	3.93e-03	24	73	2	3.40.250.10
Domain	SAP	MYOCD MRTFA	4.26e-03	25	73	2	PS50800
Domain	SAP_dom	MYOCD MRTFA	4.26e-03	25	73	2	IPR003034
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NOLC1 EME1 TCOF1 MAP4K1 PKP3 NAF1 MYO18A TJAP1 POU2F1 RIPOR1 SCRIB GPATCH8 SNAPC4 SRRM2 SPEN TFAP4 REXO1 MRTFA ZNF687	2.87e-15	774	75	19	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	NOLC1 SLC12A2 TCOF1 PPFIBP1 ATF7IP MUC16 TJAP1 SPECC1L SCRIB EPB41L3 SPEN SMCR8 NOL8	1.11e-08	777	75	13	35844135
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	NOLC1 SDE2 SERBP1 ANK2 TCOF1 ATF7IP TBC1D5 NAF1 SCRIB EPB41L3 SMCR8 AFF4 PML NOL8	1.13e-08	934	75	14	33916271
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PPP1R26 WWP1 OBSCN NINL MLLT1 RIPOR1 ZFYVE26 TANC1 JADE1 SNAPC4 ZC3H7B SPEN REXO1 MADD ZNF687	1.18e-08	1105	75	15	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	NOLC1 ZFHX4 ARHGAP23 TCOF1 WWP1 NAF1 MLLT1 TANC1 SCRIB EPB41L3 SRRM2 NCKAP5L AFF4 ZNF687 PML	1.35e-08	1116	75	15	31753913
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NOLC1 SLC12A2 PPFIBP1 MAP4K1 TBC1D5 TANC1 SCRIB EPB41L3 SRRM2 NCKAP5L REEP2 MADD PML	3.69e-08	861	75	13	36931259
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	NOLC1 RIMKLB TCOF1 PKP3 TBC1D5 NAF1 CEP41 TJAP1 RIPOR1 TNFAIP1 NCKAP5L SAPCD2 MRTFA MADD	4.21e-08	1038	75	14	26673895
Pubmed	Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.	NOLC1 TCOF1 PPFIBP1 NAF1 SRRM2 AFF4 MADD	4.90e-08	156	75	7	22952844
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	NOLC1 ZFHX4 TCOF1 GPATCH8 SPEN ZNF687	9.94e-08	103	75	6	32744500
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	AKAP6 FRMPD4 ZFYVE26 SPECC1L SRRM2 MADD	1.05e-07	104	75	6	9205841
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NOLC1 SERBP1 TCOF1 PKP3 SCRIB EPB41L3 SRRM2 SPEN MRTFA ZNF687	1.31e-07	503	75	10	16964243
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	EME1 MLLT1 REXO1 AFF4 ZNF687 PML NOL8	5.39e-07	222	75	7	37071664
Pubmed	Human transcription factor protein interaction networks.	NOLC1 ZFHX4 KBTBD6 ATF7IP MYO18A SP9 MLLT1 POU2F1 GPATCH8 SRRM2 SPEN TFAP4 ZNF687 PML	1.96e-06	1429	75	14	35140242
Pubmed	Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.	TCOF1 NAF1 SCRIB GPATCH8 EPB41L3 SRRM2 SAPCD2	1.99e-06	270	75	7	24366813
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRMPD4 RIPOR1 SCRIB GPATCH8 SRRM2 SPEN MADD MFAP3L	2.80e-06	407	75	8	12693553
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NOLC1 SLC12A2 ANK2 TCOF1 PPFIBP1 MYO18A TANC1 SCRIB EPB41L3 SRRM2 NCKAP5L SMCR8 PML NOL8	3.12e-06	1487	75	14	33957083
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NOLC1 EME1 MLX TCOF1 PKP3 MLLT1 NKTR GPATCH8 SRRM2 SPEN TFAP4 ZNF687 NOL8	3.65e-06	1294	75	13	30804502
Pubmed	Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.	MYOCD MRTFA	4.59e-06	2	75	2	31928221
Pubmed	Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells.	MYOCD MRTFA	4.59e-06	2	75	2	14970199
Pubmed	Crystallization of the Oct-1/SNAP190 peptide/DNA complex.	POU2F1 SNAPC4	4.59e-06	2	75	2	11856838
Pubmed	The transcriptional cofactor MCAF1/ATF7IP is involved in histone gene expression and cellular senescence.	ATF7IP PML	4.59e-06	2	75	2	23935871
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	NOLC1 SLC12A2 WWP1 SCRIB GPATCH8 EPB41L3 SPEN	5.26e-06	313	75	7	38270169
Pubmed	Functional specialization of beta-arrestin interactions revealed by proteomic analysis.	NOLC1 SERBP1 TCOF1 MYOCD NKTR EPB41L3 SRRM2	5.71e-06	317	75	7	17620599
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	TBC1D5 NYNRIN WWP1 MYO18A JADE1 GPATCH8 EPB41L3 ZC3H7B SPEN	6.47e-06	608	75	9	16713569
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	NOLC1 SERBP1 TCOF1 NAF1 MYO18A GPATCH8 ZC3H7B SRRM2 SPEN NOL8	9.10e-06	807	75	10	22681889
Pubmed	Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation.	MYOCD MRTFA	1.37e-05	3	75	2	17363709
Pubmed	Myocardin-related transcription factor contributes to renal fibrosis through the regulation of extracellular microenvironment surrounding fibroblasts.	MYOCD MRTFA	1.37e-05	3	75	2	37289107
Pubmed	Tanc1/2 TPR domain interacts with Myo18a C-terminus and undergoes liquid-liquid phase separation.	MYO18A TANC1	1.37e-05	3	75	2	38092135
Pubmed	RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding.	MYOCD MRTFA	1.37e-05	3	75	2	18025109
Pubmed	Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice.	MYOCD MRTFA	1.37e-05	3	75	2	23103763
Pubmed	Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.	ANK2 OBSCN	1.37e-05	3	75	2	18782775
Pubmed	Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.	ANK2 OBSCN	1.37e-05	3	75	2	12527750
Pubmed	Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.	MYOCD MRTFA	1.37e-05	3	75	2	11439182
Pubmed	Phosphorylation of proteins by inositol pyrophosphates.	NOLC1 TCOF1	1.37e-05	3	75	2	15604408
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	SERBP1 TCOF1 CEP41 SCRIB EPB41L3 SRRM2	1.58e-05	246	75	6	15345747
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	MXD3 MLX WWP1 POU2F1 MYOCD JADE1 SNAPC4 SPEN MRTFA PML	1.86e-05	877	75	10	20211142
Pubmed	The histone demethylase, Jmjd1a, interacts with the myocardin factors to regulate SMC differentiation marker gene expression.	MYOCD MRTFA	2.75e-05	4	75	2	17991879
Pubmed	Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4.	MLLT1 AFF4	2.75e-05	4	75	2	25282333
Pubmed	Potentiation of serum response factor activity by a family of myocardin-related transcription factors.	MYOCD MRTFA	2.75e-05	4	75	2	12397177
Pubmed	Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation.	MYOCD MRTFA	2.75e-05	4	75	2	16204380
Pubmed	HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold.	MLLT1 AFF4	2.75e-05	4	75	2	23251033
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SERBP1 SLC12A2 ARHGAP23 PPFIBP1 PKP3 TANC1 SCRIB EPB41L3	3.00e-05	565	75	8	25468996
Pubmed	Profiling, Bioinformatic, and Functional Data on the Developing Olfactory/GnRH System Reveal Cellular and Molecular Pathways Essential for This Process and Potentially Relevant for the Kallmann Syndrome.	AKAP6 CNGA2 ERMN	3.04e-05	28	75	3	24427155
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	SERBP1 TCOF1 DUSP6 MUC16 GPATCH8 SRRM2 SPEN	3.49e-05	420	75	7	28065597
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NOLC1 SERBP1 ATF7IP MLLT1 EPB41L3 SRRM2 SPEN AFF4 PML NOL8	3.80e-05	954	75	10	36373674
Pubmed	Thymine DNA glycosylase represses myocardin-induced smooth muscle cell differentiation by competing with serum response factor for myocardin binding.	MYOCD MRTFA	4.57e-05	5	75	2	18945672
Pubmed	Muscle-specific signaling mechanism that links actin dynamics to serum response factor.	MYOCD MRTFA	4.57e-05	5	75	2	15798203
Pubmed	The large subunit of basal transcription factor SNAPc is a Myb domain protein that interacts with Oct-1.	POU2F1 SNAPC4	4.57e-05	5	75	2	9418884
Pubmed	Activity-dependent local protection and lateral inhibition control synaptic competition in developing mitral cells in mice.	SLC12A2 CNGA2	4.57e-05	5	75	2	37290446
Pubmed	Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation.	MYOCD MRTFA	4.57e-05	5	75	2	17360478
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	MXD3 MLX POU2F1 JADE1 SNAPC4 TFAP4 MRTFA ZNF687 PML	6.02e-05	808	75	9	20412781
Pubmed	A map of protein-protein contacts within the small nuclear RNA-activating protein complex SNAPc.	POU2F1 SNAPC4	6.84e-05	6	75	2	11056176
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	ANK2 SCRIB EPB41L3	7.10e-05	37	75	3	27565344
Pubmed	ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease.	SLC12A2 ANK2 OXR1 EPB41L3 ERMN	7.80e-05	202	75	5	33601422
Pubmed	The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.	NOLC1 SERBP1 TCOF1 MYO18A SPECC1L SRRM2	7.83e-05	328	75	6	23398456
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SERBP1 SLC12A2 PPFIBP1 MLLT1 TANC1 SPECC1L GPATCH8 ZC3H7B SPEN AFF4 ZNF687 NOL8	8.19e-05	1497	75	12	31527615
Pubmed	A human MAP kinase interactome.	ATF7IP MYO18A NKTR SPECC1L EPB41L3 NCKAP5L MADD	8.72e-05	486	75	7	20936779
Pubmed	Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?	MXD3 MLX	9.57e-05	7	75	2	10918583
Pubmed	The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin.	MLLT1 AFF4	9.57e-05	7	75	2	15856011
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NOLC1 TCOF1 SRRM2 SPEN AFF4 ZNF687	9.69e-05	341	75	6	32971831
Pubmed	Proteome-wide analysis of phospho-regulated PDZ domain interactions.	FRMPD4 TANC1 SCRIB	1.04e-04	42	75	3	30126976
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ANK2 OXR1 MYO18A EPB41L3 SRRM2 MADD	1.07e-04	347	75	6	17114649
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AKAP6 NOLC1 WWP1 OBSCN JADE1 GPATCH8 AFF4 MRTFA MADD PML	1.10e-04	1084	75	10	11544199
Pubmed	The ubiquitin ligase Siah1 controls ELL2 stability and formation of super elongation complexes to modulate gene transcription.	MLLT1 AFF4	1.27e-04	8	75	2	22483617
Pubmed	Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors.	MXD3 MLX	1.27e-04	8	75	2	10593926
Pubmed	Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.	MLLT1 AFF4	1.27e-04	8	75	2	21873227
Pubmed	Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1.	SERBP1 MLLT1 AFF4	1.28e-04	45	75	3	33596420
Pubmed	RBR-type E3 ubiquitin ligase RNF144A targets PARP1 for ubiquitin-dependent degradation and regulates PARP inhibitor sensitivity in breast cancer cells.	MYO18A SCRIB EPB41L3	1.46e-04	47	75	3	29212245
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	NOLC1 ARHGAP23 PPFIBP1 MAP4K1 MLLT1 NKTR GPATCH8 AFF4 ZNF687	1.48e-04	910	75	9	36736316
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	MXD3 ATP8B3 RIMKLB MLX PKP3 TJAP1 MRTFA MADD PML	1.67e-04	925	75	9	28986522
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	PPP1R26 FRMPD4 EPB41L3 MADD	1.84e-04	130	75	4	12421765
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	NOLC1 TBC1D5 SCRIB SRRM2	2.01e-04	133	75	4	15144186
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	NOLC1 SERBP1 FRMPD4 TCOF1 PKP3 MYO18A SPECC1L SCRIB SRRM2	2.02e-04	949	75	9	36574265
Pubmed	A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.	MLLT1 AFF4	2.04e-04	10	75	2	20153263
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ANK2 TCOF1 ATF7IP TBC1D5 TJAP1 SPECC1L SCRIB EPB41L3 AFF4	2.26e-04	963	75	9	28671696
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	SERBP1 TCOF1 SCRIB GPATCH8 SRRM2 PML	2.27e-04	399	75	6	35987950
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	SLC12A2 ANK2 PPFIBP1 TBC1D5 WWP1 TANC1 SCRIB	2.30e-04	569	75	7	30639242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SERBP1 ANK2 OXR1 ARHGAP23 MYO18A TANC1 SPECC1L SCRIB EPB41L3 MADD ERMN	2.40e-04	1431	75	11	37142655
Pubmed	AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.	MLLT1 AFF4	2.49e-04	11	75	2	24367103
Pubmed	Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo.	NKTR GPATCH8	2.49e-04	11	75	2	14729963
Pubmed	HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.	MLLT1 AFF4	2.49e-04	11	75	2	20471949
Pubmed	The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA.	NOLC1 PKP3 TNFAIP1 ZNF687 PML	2.62e-04	262	75	5	36880596
Pubmed	The little elongation complex regulates small nuclear RNA transcription.	MLLT1 AFF4	2.99e-04	12	75	2	22195968
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	NOLC1 TCOF1 AFF4 NOL8	3.03e-04	148	75	4	32538781
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	NOLC1 SERBP1 ZFHX4 TCOF1 SRRM2 SPEN ZNF687	3.32e-04	605	75	7	28977666
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SLC12A2 TCOF1 MAP4K1 TBC1D5 SPEN MRTFA	3.38e-04	430	75	6	35044719
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	NOLC1 TCOF1 MLLT1 EPB41L3 AFF4 ZNF687	3.47e-04	432	75	6	23455922
Pubmed	Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function.	MYOCD MRTFA	3.52e-04	13	75	2	29114040
Pubmed	Transcriptional and posttranscriptional regulation of HIV-1 gene expression.	MLLT1 AFF4	3.52e-04	13	75	2	22355797
Pubmed	Establishment of a Wheat Cell-Free Synthesized Protein Array Containing 250 Human and Mouse E3 Ubiquitin Ligases to Identify Novel Interaction between E3 Ligases and Substrate Proteins.	WWP1 DCST1	3.52e-04	13	75	2	27249653
Pubmed	The transcription factor Foxf1 binds to serum response factor and myocardin to regulate gene transcription in visceral smooth muscle cells.	MYOCD MRTFA	3.52e-04	13	75	2	23946491
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	NOLC1 SERBP1 PPFIBP1 PKP3 MYO18A SPECC1L SCRIB SPEN PML NOL8	3.60e-04	1257	75	10	36526897
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	TCOF1 NKTR SCRIB GPATCH8 ZNF687 PML	3.82e-04	440	75	6	34244565
Pubmed	FAM188B enhances cell survival via interaction with USP7.	SERBP1 TCOF1 SRRM2	3.82e-04	65	75	3	29795372
Pubmed	A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.	SERBP1 WWP1 REEP2	3.82e-04	65	75	3	22379092
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	SERBP1 TCOF1 PPFIBP1 PKP3 MYO18A SPECC1L SRRM2	4.08e-04	626	75	7	33644029
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	PPFIBP1 TBC1D5 NYNRIN NINL EPB41L3 NCKAP5L	4.10e-04	446	75	6	24255178
Pubmed	A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.	ATF7IP POU2F1	4.11e-04	14	75	2	10976766
Pubmed	MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.	MLLT1 AFF4	4.11e-04	14	75	2	20854876
Pubmed	Cell-fate determination by ubiquitin-dependent regulation of translation.	NOLC1 TCOF1	4.11e-04	14	75	2	26399832
Interaction	PLCD4 interactions	NOLC1 KBTBD6 TCOF1 MLLT1 SNAPC4 AFF4 ZNF687	2.32e-11	32	75	7	int:PLCD4
Interaction	PIP4K2A interactions	NOLC1 TCOF1 NAF1 MLLT1 SCRIB GPATCH8 EPB41L3 SRRM2 SPEN AFF4 MADD	4.46e-10	216	75	11	int:PIP4K2A
Interaction	CAMKV interactions	NOLC1 TCOF1 NAF1 MLLT1 GPATCH8 SRRM2 SPEN AFF4	1.32e-08	118	75	8	int:CAMKV
Interaction	NFKBIL1 interactions	NOLC1 KBTBD6 GPATCH8 SNAPC4 SRRM2 SPEN AFF4	5.45e-08	93	75	7	int:NFKBIL1
Interaction	ARRB2 interactions	NOLC1 SERBP1 TCOF1 NINL MLLT1 POU2F1 MYOCD NKTR EPB41L3 SRRM2 TFAP4 AFF4	1.07e-07	454	75	12	int:ARRB2
Interaction	DENND2D interactions	NOLC1 TCOF1 MLLT1 SRRM2 AFF4	2.15e-07	36	75	5	int:DENND2D
Interaction	CT45A5 interactions	NOLC1 KBTBD6 NAF1 SNAPC4 SPEN AFF4	4.50e-07	78	75	6	int:CT45A5
Interaction	CSNK2B interactions	NOLC1 MLX TCOF1 MAP4K1 BIRC3 NKTR TNFAIP1 JADE1 SNAPC4 EPB41L3 MADD ZNF687 PML	4.69e-07	625	75	13	int:CSNK2B
Interaction	GRK5 interactions	NOLC1 TCOF1 PPFIBP1 NAF1 SRRM2 AFF4 MADD	5.16e-06	182	75	7	int:GRK5
Interaction	PLCD3 interactions	NOLC1 TCOF1 NAF1 MLLT1 SPEN AFF4	5.94e-06	121	75	6	int:PLCD3
Interaction	EPB41L3 interactions	SERBP1 NAF1 MLLT1 GPATCH8 EPB41L3 SRRM2 AFF4 PML	7.67e-06	272	75	8	int:EPB41L3
Interaction	FLOT1 interactions	SERBP1 SLC12A2 ANK2 PPFIBP1 WWP1 BIRC3 TANC1 SCRIB EPB41L3 NCKAP5L	1.01e-05	475	75	10	int:FLOT1
Interaction	YWHAH interactions	NOLC1 SERBP1 SLC12A2 PPFIBP1 TBC1D5 NINL NKTR TANC1 SPECC1L SCRIB EPB41L3 SRRM2 NCKAP5L REEP2 MADD	1.10e-05	1102	75	15	int:YWHAH
Interaction	NAA40 interactions	NOLC1 SDE2 SERBP1 ANK2 TCOF1 ATF7IP TBC1D5 NAF1 SCRIB EPB41L3 SMCR8 AFF4 PML NOL8	1.29e-05	978	75	14	int:NAA40
Interaction	FGF12 interactions	NOLC1 KBTBD6 TCOF1 MLLT1 AFF4	1.82e-05	87	75	5	int:FGF12
Interaction	ARRDC3 interactions	NOLC1 SLC12A2 WWP1 SCRIB GPATCH8 EPB41L3 SPEN	1.99e-05	224	75	7	int:ARRDC3
Interaction	SYT2 interactions	NOLC1 NAF1 MLLT1 GPATCH8 AFF4 MADD	2.03e-05	150	75	6	int:SYT2
Interaction	HTATSF1 interactions	NOLC1 SERBP1 TCOF1 NAF1 MLLT1 SPEN	2.63e-05	157	75	6	int:HTATSF1
Interaction	MAP1LC3B interactions	NOLC1 ANK2 KBTBD6 TCOF1 PKP3 TBC1D5 RIPOR1 ZC3H7B MRTFA PML	3.62e-05	551	75	10	int:MAP1LC3B
Interaction	EZR interactions	NOLC1 SLC12A2 ANK2 PPFIBP1 WWP1 DUSP6 BIRC3 TANC1 SCRIB PML	3.73e-05	553	75	10	int:EZR
Interaction	FXR1 interactions	SERBP1 TCOF1 PKP3 DUSP6 MLLT1 BIRC3 TNFAIP1 SCRIB EPB41L3 ZC3H7B PML	4.04e-05	679	75	11	int:FXR1
Interaction	CSNK2A1 interactions	NOLC1 SERBP1 MLX TCOF1 NAF1 MLLT1 BIRC3 NKTR SNAPC4 EPB41L3 SRRM2 ZNF687 PML	4.67e-05	956	75	13	int:CSNK2A1
Interaction	YWHAG interactions	NOLC1 SERBP1 MLX ARHGAP23 PPFIBP1 TBC1D5 NINL NKTR TANC1 SPECC1L SCRIB EPB41L3 SRRM2 NCKAP5L REEP2	4.70e-05	1248	75	15	int:YWHAG
Interaction	SFN interactions	NOLC1 SERBP1 PPFIBP1 PKP3 TBC1D5 NINL TANC1 JADE1 SCRIB SRRM2 NCKAP5L	4.79e-05	692	75	11	int:SFN
Interaction	DAXX interactions	NOLC1 SERBP1 ATF7IP NAF1 SRRM2 SPEN AFF4 PML	4.97e-05	353	75	8	int:DAXX
Interaction	NUAK2 interactions	TCOF1 NAF1 EPB41L3 SRRM2	5.61e-05	56	75	4	int:NUAK2
Interaction	ATRX interactions	SERBP1 ANK2 ZFHX4 NAF1 EPB41L3 ZNF687 PML	6.10e-05	267	75	7	int:ATRX
Interaction	FAM9A interactions	NOLC1 NAF1 SRRM2 AFF4	6.90e-05	59	75	4	int:FAM9A
Interaction	EPB41L1 interactions	NAF1 MLLT1 GPATCH8 EPB41L3 SRRM2 AFF4	6.97e-05	187	75	6	int:EPB41L1
Interaction	DDX23 interactions	NOLC1 TCOF1 NAF1 MLLT1 NKTR GPATCH8 SRRM2 AFF4 NOL8	7.13e-05	480	75	9	int:DDX23
Interaction	PCNA interactions	SDE2 ARHGAP23 TCOF1 OBSCN NINL BIRC3 TNFAIP1 TFAP4 PML	9.30e-05	497	75	9	int:PCNA
Interaction	RASA2 interactions	NOLC1 TCOF1 AFF4	1.21e-04	26	75	3	int:RASA2
Interaction	EPB41L2 interactions	SERBP1 MLLT1 BIRC3 GPATCH8 EPB41L3 SRRM2 PML	1.24e-04	299	75	7	int:EPB41L2
Interaction	NHP2 interactions	NOLC1 SERBP1 TCOF1 NAF1 BIRC3	1.29e-04	131	75	5	int:NHP2
Interaction	SAP18 interactions	NOLC1 NINL NKTR GPATCH8 EPB41L3 SRRM2 PML	1.40e-04	305	75	7	int:SAP18
Interaction	DNAJC17 interactions	NOLC1 TCOF1 SRRM2 PML NOL8	1.43e-04	134	75	5	int:DNAJC17
Interaction	PAF1 interactions	NOLC1 SERBP1 TCOF1 MLLT1 AFF4 PML	1.46e-04	214	75	6	int:PAF1
Interaction	RPL15 interactions	NOLC1 SERBP1 MYO18A BIRC3 NKTR SPECC1L ZNF687 PML NOL8	1.51e-04	530	75	9	int:RPL15
Interaction	TERF2IP interactions	SDE2 KBTBD6 ATF7IP SRRM2 SPEN TFAP4 AFF4 ZNF687 PML	2.05e-04	552	75	9	int:TERF2IP
Interaction	CDK12 interactions	NOLC1 SERBP1 MLLT1 SRRM2 SPEN AFF4	2.06e-04	228	75	6	int:CDK12
Interaction	APEX1 interactions	NOLC1 MXD3 ATP8B3 RIMKLB MLX TCOF1 PKP3 TJAP1 TFAP4 AFF4 MRTFA MADD PML NOL8	2.19e-04	1271	75	14	int:APEX1
Interaction	H2BC9 interactions	EME1 SERBP1 ZFHX4 CEP41 SPECC1L GPATCH8 REEP2 AFF4	2.49e-04	446	75	8	int:H2BC9
Interaction	SLX4 interactions	EME1 SERBP1 ATF7IP MLLT1 REXO1 AFF4 ZNF687 PML NOL8	2.66e-04	572	75	9	int:SLX4
Interaction	ELOA interactions	SERBP1 NAF1 NINL SPECC1L REXO1 AFF4	2.84e-04	242	75	6	int:ELOA
Interaction	TOP3B interactions	PPP1R26 WWP1 OBSCN NINL MLLT1 RIPOR1 ZFYVE26 TANC1 JADE1 SNAPC4 ZC3H7B SPEN REXO1 MADD ZNF687	2.90e-04	1470	75	15	int:TOP3B
Interaction	CSNK2A2 interactions	NOLC1 SERBP1 MLX TCOF1 BIRC3 NKTR SNAPC4 EPB41L3 SRRM2 ZNF687	3.17e-04	718	75	10	int:CSNK2A2
Interaction	PIP4K2C interactions	NOLC1 SCRIB EPB41L3 AFF4 MADD	3.17e-04	159	75	5	int:PIP4K2C
Interaction	PALS1 interactions	WWP1 NINL RIPOR1 EPB41L3	3.40e-04	89	75	4	int:PALS1
Interaction	YWHAB interactions	SERBP1 MLX ARHGAP23 PPFIBP1 TBC1D5 NINL TANC1 SCRIB EPB41L3 SRRM2 NCKAP5L REEP2	3.43e-04	1014	75	12	int:YWHAB
Interaction	PES1 interactions	NOLC1 SERBP1 NAF1 BIRC3 SRRM2 AFF4	4.00e-04	258	75	6	int:PES1
Interaction	PXK interactions	NOLC1 TCOF1 SRRM2	4.77e-04	41	75	3	int:PXK
GeneFamily	Basic helix-loop-helix proteins\|MAX dimerization proteins	MXD3 MLX	1.56e-04	7	50	2	637
GeneFamily	AF4/FMR2 family\|Super elongation complex	MLLT1 AFF4	2.67e-04	9	50	2	1280
GeneFamily	PDZ domain containing	FRMPD4 ARHGAP23 MYO18A SCRIB	8.19e-04	152	50	4	1220
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	SMCR8 MADD	2.16e-03	25	50	2	504
GeneFamily	Basic helix-loop-helix proteins	MXD3 MLX TFAP4	3.49e-03	110	50	3	420
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	FRMPD4 EPB41L3	8.44e-03	50	50	2	1293
Coexpression	NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP	NOLC1 MLX OXR1 TBC1D5 WWP1 DUSP6 TJAP1 TNFAIP1 JADE1	7.87e-06	477	74	9	M40930
Coexpression	AIZARANI_LIVER_C20_LSECS_3	NOLC1 ARHGAP23 PPFIBP1 DUSP6 RIPOR1 TANC1 AFF4	2.01e-05	295	74	7	M39121
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	AKAP6 NOLC1 TCOF1 ATF7IP EPB41L3 SPEN	3.67e-05	219	74	6	M41199
Coexpression	RIEGE_DELTANP63_DIRECT_TARGETS_UP	ARHGAP23 TCOF1 PPFIBP1 DUSP6 TMEM40	4.53e-05	138	74	5	M41739
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	TCOF1 SNAPC4 ZC3H7B SRRM2 NCKAP5L REXO1 NOL8	4.78e-05	338	74	7	M17094
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500	NOLC1 EME1 TCOF1 NAF1 NINL SP9 POU2F1 JADE1 REEP2 NOL8	7.35e-06	496	73	10	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500
CoexpressionAtlas	facebase_RNAseq_e9.5_MandArch_2500_K3	NOLC1 EME1 SDE2 MLX TCOF1 MAP4K1 NAF1 MYO18A NINL MLLT1 TJAP1 SCRIB ZC3H7B NCKAP5L TFAP4	2.03e-05	1259	73	15	facebase_RNAseq_e9.5_MandArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000	NOLC1 EME1 SDE2 SERBP1 TCOF1 NAF1 NINL SP9 POU2F1 JADE1 REEP2 TFAP4 NOL8	2.94e-05	991	73	13	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4	EME1 NINL POU2F1 JADE1 NOL8	6.85e-05	124	73	5	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	EME1 SERBP1 NINL POU2F1 JADE1 NOL8	7.28e-05	204	73	6	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1	NOLC1 POU2F1 REEP2 NOL8 ERMN	1.43e-04	145	73	5	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K1
ToppCell	HSPCs-Mk_prog.\|World / Lineage and Cell class	SERBP1 MAP4K1 OBSCN REEP2 TMEM40 MADD	9.35e-07	194	75	6	5049f4f102844d766eca577e809cf21f7908a9d2
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MXD3 EME1 POU2F1 LY9 PML	1.01e-05	170	75	5	e08a6c5ac34c456da8c7318f104e06fca585be1f
ToppCell	facs-Heart-LV-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4K1 PKP3 ILDR1 LY9 SPINK5	1.04e-05	171	75	5	c6fc9ef9735dbf5314a4c7dac2b2954b0985ae4d
ToppCell	facs-Heart-LV-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4K1 PKP3 ILDR1 LY9 SPINK5	1.04e-05	171	75	5	55b194a9bf4d3e4b5d96e0d1298424359c441cbb
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	EME1 KBTBD6 DCST1 TMEM40	1.49e-05	88	75	4	2075743c7c0b6d74e80464a6bc776206d744d502
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	EME1 KBTBD6 DCST1 TMEM40	1.49e-05	88	75	4	a49319bc97188550e08248973e10c626124c3917
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	EME1 KBTBD6 DCST1 TMEM40	1.49e-05	88	75	4	14b11249a2b3fa327622897fe74630c2697ea47e
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	AKAP6 ANK2 PPFIBP1 OBSCN MYOCD	1.52e-05	185	75	5	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	AKAP6 ANK2 OBSCN MYOCD TANC1	1.64e-05	188	75	5	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	AKAP6 ANK2 PPFIBP1 OBSCN MYOCD	1.69e-05	189	75	5	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	(02)_Cycling_Basal_(regeneration)-(1)_24hpi\|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint	NOLC1 SERBP1 DUSP6 TNFAIP1 EPB41L3	1.69e-05	189	75	5	311f3aed469be3c8ff913dcc5a2442daa8446d55
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	AKAP6 ANK2 OBSCN MYOCD TANC1	1.69e-05	189	75	5	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	AKAP6 ANK2 OBSCN MYOCD TANC1	1.73e-05	190	75	5	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	Severe-B_activate-7\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RIMKLB TCOF1 ATF7IP BIRC3 LY9	1.73e-05	190	75	5	67e6c8a5a8724bdf2861fd76a711319dfc71d47a
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	AKAP6 ANK2 PPFIBP1 OBSCN MYOCD	1.73e-05	190	75	5	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	AKAP6 ANK2 OBSCN MYOCD TANC1	1.77e-05	191	75	5	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	AKAP6 ANK2 OBSCN MYOCD TANC1	1.82e-05	192	75	5	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCOF1 ATF7IP BIRC3 RIPOR1 LY9	1.91e-05	194	75	5	5cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	AKAP6 ANK2 OBSCN MYOCD TANC1	1.91e-05	194	75	5	c3535f7cc0076653c72db582047cff053c322397
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKTR EPB41L3 SRRM2 AFF4 MADD	1.96e-05	195	75	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC12A2 ANK2 ARHGAP23 EPB41L3 ERMN	2.11e-05	198	75	5	fef9a4c96450078527b94d25e681410e4ea01b13
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 PPFIBP1 MLLT1 JADE1 GPATCH8	2.16e-05	199	75	5	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC12A2 ANK2 ARHGAP23 EPB41L3 ERMN	2.21e-05	200	75	5	0e85c90719d9ec51a566e230c9dd2909d8df1f52
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MXD3 EME1 KBTBD6 SAPCD2	9.71e-05	142	75	4	7bd05d0c0ac2dee0e6cc0f3c531f9154bf300c75
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P4\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MXD3 EME1 KBTBD6 SAPCD2	9.71e-05	142	75	4	328d08ba2712cd42bb9846ac4d7453ae165b75e2
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MXD3 EME1 KBTBD6 SAPCD2	9.71e-05	142	75	4	94774d3e598d074f48146b0b094705dc48af5a1f
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MXD3 EME1 KBTBD6 SAPCD2	9.71e-05	142	75	4	92bf826827b3e3387ad326566556fc90c5c2f4d5
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MXD3 NCKAP5L SAPCD2 TFAP4	1.36e-04	155	75	4	8e239470799426ea474a36f57e1b7e0d9365ca5f
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP23 BIRC3 ILDR1 SMCR8	1.54e-04	160	75	4	c2b5fadb4bac17fafc08831f6d3f4ff96ada7e70
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MXD3 EME1 MAP4K1 SAPCD2	1.58e-04	161	75	4	0dd1401b4c990d49fccb702a9f9867590a58e203
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MXD3 EME1 MAP4K1 SAPCD2	1.58e-04	161	75	4	b6a31c033edc74f23a20aab1f18e80cc83ffee4c
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P5\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MXD3 EME1 MAP4K1 SAPCD2	1.58e-04	161	75	4	efb811dda4d73107983a5f68302bdcf4f408d5b4
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP23 ILDR1 REEP2 MFAP3L	1.58e-04	161	75	4	22fea192cd5f6d3544533d8b10e1d74dfedf0f05
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MXD3 EME1 MAP4K1 SAPCD2	1.58e-04	161	75	4	28d5dbd20c9f8e0069f172d552997a044790e1a7
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCOF1 NAF1 BIRC3 RIPOR1	1.73e-04	165	75	4	83095377aedf960c05baa523869bdbd2b0a05f2d
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZFHX4 PKP3 SCRIB SPINK5	1.77e-04	166	75	4	9fd9de82f98b9acdaa59ac98fb9664161514aec0
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	ATF7IP TBC1D5 OBSCN POU2F1	1.77e-04	166	75	4	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-9\|TCGA-Colorectal / Sample_Type by Project: Shred V9	AKAP6 FRMPD4 ANK2 REEP2	1.77e-04	166	75	4	68e6fc7c0040bbe48a93f96ecf28afffdc626845
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	SLC12A2 ARHGAP23 PPFIBP1 OBSCN	1.81e-04	167	75	4	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MXD3 EME1 RIMKLB SAPCD2	1.81e-04	167	75	4	d21635df8b74189e3309eaf435af381fbe412574
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EME1 ZFYVE26 SAPCD2 MRTFA	1.85e-04	168	75	4	9b8a74abb83c64f0b5829dcb4275f722c82b45dc
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EME1 ZFYVE26 SAPCD2 MRTFA	1.85e-04	168	75	4	4b152b8d0f4a66faf664dfacb7914b18d60ce64a
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EME1 ZFYVE26 SAPCD2 MRTFA	1.85e-04	168	75	4	c3169ad8f4130ef18777ed86770bb722ffb5db85
ToppCell	3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages\|Lung / Manually curated celltypes from each tissue	AKAP6 NYNRIN DUSP6 NCKAP5L	1.90e-04	169	75	4	241644823e6f949aaf4c671d4579721d7ef6b0e5
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 ANK2 OBSCN MYOCD	1.94e-04	170	75	4	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	Mild_COVID-19-Myeloid-MoAM5\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	RIMKLB TANC1 TMEM40 SPINK5	1.94e-04	170	75	4	b2daf46ab5a49590ede8f75e4240bfe6e9d8b764
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 NINL LY9 EPB41L3	1.94e-04	170	75	4	a121e10099faaeb60251eec162f38caf7c4238c2
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-basal_late\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PKP3 BIRC3 TMEM40 SPINK5	1.94e-04	170	75	4	83320d37f0fc74e492cfe3de18f5c499eaa9fd3e
ToppCell	PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP4K1 TBC1D5 MADD NOL8	2.07e-04	173	75	4	28c98a9a54aa2cfa67464db4f628c9357ad185b9
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO18A SPECC1L EPB41L3 MFAP3L	2.07e-04	173	75	4	e1378201b15ffb98e196ac39fe3ee4b4078953bd
ToppCell	facs-Large_Intestine-Proximal-3m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO18A SPECC1L EPB41L3 MFAP3L	2.07e-04	173	75	4	99532bb768ee35fed939a377acb5215d3f8904bd
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MUC16 ILDR1 SAPCD2 SPINK5	2.12e-04	174	75	4	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 NINL LY9 EPB41L3	2.17e-04	175	75	4	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PKP3 MUC16 TMEM40 SPINK5	2.21e-04	176	75	4	8d9d0fb46c418b2067be58aec822e8c2b1561461
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 ANK2 OBSCN MYOCD	2.21e-04	176	75	4	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R26 ARHGAP23 ZC3H7B MRTFA	2.26e-04	177	75	4	f6b9d91d46830d0d207b0abd4ee5a4942fd99774
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	AKAP6 PPP1R26 MYO18A POU2F1	2.26e-04	177	75	4	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MXD3 ATP8B3 EME1 SAPCD2	2.31e-04	178	75	4	ea10117026021c959ffc871fc377cdb3e161d264
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 NKTR TANC1 AFF4	2.36e-04	179	75	4	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Control-Lymphoid-B\|World / Disease state, Lineage and Cell class	MAP4K1 ATF7IP BIRC3 LY9	2.46e-04	181	75	4	9124f1a610cfc3355ad87921cd3eb5346956475d
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 ANK2 OBSCN MYOCD	2.46e-04	181	75	4	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAP4K1 ATF7IP BIRC3 LY9	2.46e-04	181	75	4	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SERBP1 TCOF1 MAP4K1 PML	2.57e-04	183	75	4	956ff95aef9c5521b6a3ba7ac6df0aad242c1c35
ToppCell	droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOLC1 TCOF1 NAF1 TFAP4	2.57e-04	183	75	4	92ef926e6c1de8477fa4f35d1dae85482d8009de
ToppCell	droplet-Marrow-nan-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOLC1 TCOF1 NAF1 TFAP4	2.57e-04	183	75	4	24db9cc717e651586317c6a8e03a3401651273c1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 ZFHX4 OBSCN MYOCD	2.62e-04	184	75	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	Control-Lymphoid-B\|Control / Disease state, Lineage and Cell class	MAP4K1 ATF7IP BIRC3 LY9	2.62e-04	184	75	4	de0294f879268bfd68e91adcc2adba211d221b7a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 ZFHX4 OBSCN MYOCD	2.62e-04	184	75	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 ZFHX4 OBSCN MYOCD	2.62e-04	184	75	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	AKAP6 ANK2 OBSCN MYOCD	2.62e-04	184	75	4	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 ANK2 OBSCN MYOCD	2.62e-04	184	75	4	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 ANK2 OBSCN MYOCD	2.68e-04	185	75	4	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	SP9 NKTR JADE1 SRRM2	2.68e-04	185	75	4	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage-stroma-osteoclast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	AKAP6 OXR1 BIRC3 ILDR1	2.68e-04	185	75	4	5ed49b6d8214c6119355a6d3ee4e25d40bcc0c53
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 ATP8B3 ANK2 REEP2	2.68e-04	185	75	4	94d0f283d63d932f310cc5a17ea893d71ba60f5e
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	EME1 MAP4K1 TMEM40	2.76e-04	75	75	3	9a82db6281326acc534b800e02b262a8617a147e
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Pdgfa_(Pdgfa)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	EME1 MAP4K1 TMEM40	2.76e-04	75	75	3	7678e7d514560c774b56fc0a20312d561c89f587
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	EME1 MAP4K1 TMEM40	2.76e-04	75	75	3	7f1fc575fca42352434f7188c7a95b50372aeefa
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	AKAP6 PPFIBP1 OBSCN MYOCD	2.79e-04	187	75	4	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATF7IP NYNRIN MYOCD SPECC1L	2.85e-04	188	75	4	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATF7IP NYNRIN MYOCD SPECC1L	2.85e-04	188	75	4	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATF7IP NYNRIN MYOCD SPECC1L	2.85e-04	188	75	4	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	normal-na-Lymphocytic_B-B_naive-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	AKAP6 TCOF1 ATF7IP BIRC3	2.85e-04	188	75	4	ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	AKAP6 PPFIBP1 OBSCN MYOCD	2.85e-04	188	75	4	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENHO CEP41 OBSCN MYOCD	2.85e-04	188	75	4	40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1
ToppCell	10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	AKAP6 OXR1 BIRC3 ILDR1	2.85e-04	188	75	4	762b52f21d2bc5409f86746a904c4358490be9c0
ToppCell	facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENHO CEP41 OBSCN MYOCD	2.85e-04	188	75	4	ba7f7ce034c0f42742bf2461f68f8d343ee593a5
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_activate-7\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCOF1 ATF7IP BIRC3 LY9	2.90e-04	189	75	4	ef33cc03728a78423ee92d2ef1ffed4918d4221f
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 NINL ILDR1 TANC1	2.90e-04	189	75	4	e127e3be626bc513e151d41812f0b7adb89d5da6
ToppCell	cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO18A RIPOR1 SNAPC4 NCKAP5L	2.90e-04	189	75	4	bccb3481ffed597c845fe860da658505316105b5
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	AKAP6 ANK2 OBSCN MYOCD	2.90e-04	189	75	4	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 NINL ILDR1 TANC1	2.90e-04	189	75	4	ff637ae0afdb1fdc67451be7e1e4fe575fbcfff4
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	AKAP6 ANK2 PPFIBP1 OBSCN	2.96e-04	190	75	4	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 ANK2 OBSCN MYOCD	2.96e-04	190	75	4	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)-SMG_serous_(nasal)_L.0.6.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLC12A2 OXR1 CEP41 ERMN	2.96e-04	190	75	4	70b14b649ae893513e6d61b7288d6f6df97f09d9
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC12A2 PPFIBP1 OBSCN TANC1	2.96e-04	190	75	4	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 NINL ILDR1 TANC1	2.96e-04	190	75	4	c408d4033a130c0168159a5b6f286fd2b2a9a39d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCOF1 ATF7IP BIRC3 LY9	2.96e-04	190	75	4	0724665ac8238f2383c3a929d89abf4a48ec2420
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 NINL ILDR1 TANC1	2.96e-04	190	75	4	d4910c37045a8b8bb53b37625263bc0a47b6e3f8
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MXD3 EME1 SAPCD2 ERMN	3.02e-04	191	75	4	15dbc5a03bfab8931c0fd385b0f25874736ae874
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	MLX PPFIBP1 TJAP1 ZFYVE26 TNFAIP1 ZC3H7B TFAP4 MFAP3L	2.21e-07	191	75	8	1080_UP
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	NYNRIN NKTR SNAPC4 ZC3H7B TFAP4 AFF4 PML	4.35e-06	200	75	7	6679_DN
Drug	Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	DUSP6 NKTR ZC3H7B TFAP4 MFAP3L PML	4.01e-05	191	75	6	2250_DN
Drug	Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A	RIPOR1 SNAPC4 ZC3H7B SRRM2 SPEN TFAP4	4.38e-05	194	75	6	5362_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	ANK2 ZFHX4 TBC1D5 SNAPC4 ZC3H7B PML	4.38e-05	194	75	6	6171_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	ZFHX4 NYNRIN TJAP1 TNFAIP1 ZC3H7B TFAP4	4.38e-05	194	75	6	7000_UP
Drug	Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CEP41 BIRC3 TJAP1 REEP2 MFAP3L PML	4.50e-05	195	75	6	1539_UP
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	NYNRIN TJAP1 RIPOR1 ZC3H7B TFAP4 PML	4.50e-05	195	75	6	4180_DN
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A	NYNRIN BIRC3 TNFAIP1 AFF4 MRTFA PML	4.50e-05	195	75	6	6661_DN
Drug	Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	NOLC1 RIPOR1 NKTR TNFAIP1 SNAPC4 ZC3H7B	4.63e-05	196	75	6	2103_DN
Drug	Hydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A	DUSP6 TJAP1 REEP2 MRTFA MFAP3L PML	4.63e-05	196	75	6	1687_UP
Drug	Ebselen [60940-34-3]; Up 200; 14.6uM; HL60; HT_HG-U133A	PKP3 CEP41 TNFAIP1 SRRM2 AFF4 MFAP3L	4.63e-05	196	75	6	2717_UP
Drug	Iopromide [73334-07-3]; Up 200; 5uM; PC3; HT_HG-U133A	SNAPC4 ZC3H7B SRRM2 TMEM40 MFAP3L SPINK5	4.77e-05	197	75	6	4504_UP
Drug	CP-645525-01 [287190-82-3]; Down 200; 10uM; MCF7; HT_HG-U133A	MXD3 SNAPC4 ZC3H7B TFAP4 MRTFA PML	4.77e-05	197	75	6	7522_DN
Drug	Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A	NYNRIN RIPOR1 ZC3H7B MRTFA PML SPINK5	4.77e-05	197	75	6	4158_DN
Drug	Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A	MXD3 NKTR TNFAIP1 TFAP4 MRTFA PML	4.77e-05	197	75	6	6611_DN
Drug	Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	ZFHX4 MLX RIPOR1 ZC3H7B PML SPINK5	4.77e-05	197	75	6	7334_UP
Drug	0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A	NYNRIN TNFAIP1 SNAPC4 ZC3H7B MRTFA SPINK5	4.77e-05	197	75	6	7052_UP
Drug	Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A	TCOF1 NKTR TNFAIP1 SNAPC4 ZC3H7B SRRM2	4.77e-05	197	75	6	6279_DN
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A	MXD3 CEP41 TJAP1 TNFAIP1 TFAP4 MRTFA	4.77e-05	197	75	6	3692_DN
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A	NKTR TNFAIP1 ZC3H7B MRTFA MFAP3L PML	4.77e-05	197	75	6	7192_UP
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	NYNRIN TJAP1 TFAP4 MRTFA PML SPINK5	4.77e-05	197	75	6	2327_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A	PKP3 RIPOR1 GPATCH8 SRRM2 MRTFA PML	4.90e-05	198	75	6	2106_UP
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ANK2 NYNRIN DUSP6 BIRC3 NKTR PML	4.90e-05	198	75	6	6037_UP
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A	MXD3 NYNRIN TJAP1 SNAPC4 ZC3H7B PML	4.90e-05	198	75	6	7549_UP
Drug	Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A	TJAP1 NKTR TNFAIP1 SNAPC4 ZC3H7B PML	4.90e-05	198	75	6	4569_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	PPFIBP1 TNFAIP1 SNAPC4 ZC3H7B MRTFA PML	4.90e-05	198	75	6	2054_DN
Drug	Phensuximide [86-34-0]; Up 200; 21.2uM; HL60; HT_HG-U133A	MXD3 PPFIBP1 CEP41 BIRC3 TFAP4 MRTFA	4.90e-05	198	75	6	2960_UP
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; HL60; HT_HG-U133A	PPP1R26 MXD3 BIRC3 RIPOR1 ZC3H7B TFAP4	5.04e-05	199	75	6	6148_DN
Drug	Paclitaxel [33069-62-4]; Up 200; 4.6uM; PC3; HG-U133A	NOLC1 PKP3 DUSP6 POU2F1 TNFAIP1 GPATCH8	5.04e-05	199	75	6	1959_UP
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	AKAP6 TBC1D5 BIRC3 TJAP1 MRTFA PML	5.04e-05	199	75	6	5475_UP
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A	MXD3 TBC1D5 LY9 ZC3H7B MRTFA PML	5.04e-05	199	75	6	2400_DN
Drug	Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A	MXD3 TBC1D5 ZC3H7B SRRM2 MRTFA PML	5.04e-05	199	75	6	2769_DN
Drug	Thimerosal	ATP8B3 SLC12A2 ANK2 PPFIBP1 MAP4K1 ATF7IP NYNRIN BIRC3 SRRM2 SPEN SAPCD2 AFF4 PML	1.35e-04	1199	75	13	ctd:D013849
Drug	Beta-Escin [11072-93-8]; Up 200; 3.2uM; PC3; HT_HG-U133A	BIRC3 SNAPC4 TFAP4 AFF4 PML	2.76e-04	174	75	5	4544_UP
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	TBC1D5 NKTR GPATCH8 SRRM2 SPEN	2.98e-04	177	75	5	985_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	TBC1D5 NKTR GPATCH8 SRRM2 SPEN	3.14e-04	179	75	5	4585_DN
Drug	Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	MXD3 BIRC3 EPB41L3 SRRM2 PML	3.39e-04	182	75	5	5010_UP
Drug	Monobenzone [103-16-2]; Down 200; 20uM; MCF7; HT_HG-U133A	PPFIBP1 TNFAIP1 SRRM2 MRTFA SPINK5	3.75e-04	186	75	5	3391_DN
Drug	Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A	MLX TJAP1 LY9 MADD PML	3.84e-04	187	75	5	7368_UP
Drug	rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A	MXD3 BIRC3 ZC3H7B TFAP4 AFF4	3.84e-04	187	75	5	4457_DN
Drug	Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A	PPP1R26 MXD3 NINL RIPOR1 PML	3.84e-04	187	75	5	6764_DN
Drug	Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; HL60; HG-U133A	NOLC1 TCOF1 SNAPC4 ZC3H7B MADD	3.93e-04	188	75	5	1622_DN
Drug	Azacyclonol [115-46-8]; Up 200; 15uM; PC3; HT_HG-U133A	NYNRIN BIRC3 SNAPC4 TFAP4 AFF4	3.93e-04	188	75	5	6298_UP
Drug	2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A	SNAPC4 SRRM2 TFAP4 MRTFA PML	4.03e-04	189	75	5	410_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	PKP3 RIPOR1 SNAPC4 ZC3H7B TFAP4	4.13e-04	190	75	5	836_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	MXD3 TJAP1 SNAPC4 TFAP4 MRTFA	4.13e-04	190	75	5	6956_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	PPFIBP1 RIPOR1 NKTR TNFAIP1 TFAP4	4.13e-04	190	75	5	5223_DN
Drug	Dienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A	MXD3 ZFHX4 TJAP1 MRTFA PML	4.23e-04	191	75	5	3448_UP
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	TBC1D5 NKTR TNFAIP1 SNAPC4 SPEN	4.23e-04	191	75	5	4269_DN
Drug	lomustine; Down 200; 100uM; MCF7; HT_HG-U133A	MXD3 NYNRIN TFAP4 PML SPINK5	4.23e-04	191	75	5	7045_DN
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A	NOLC1 NKTR SRRM2 TFAP4 PML	4.33e-04	192	75	5	1792_UP
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	SNAPC4 TFAP4 MRTFA MFAP3L SPINK5	4.33e-04	192	75	5	3382_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A	NOLC1 NKTR TNFAIP1 SNAPC4 SPEN	4.33e-04	192	75	5	4268_DN
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; HL60; HT_HG-U133A	ANK2 TCOF1 ZC3H7B TFAP4 MRTFA	4.33e-04	192	75	5	3046_DN
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A	NYNRIN TJAP1 TNFAIP1 ZC3H7B TFAP4	4.33e-04	192	75	5	4144_DN
Drug	oxolinic acid	MLX OXR1 TFAP4	4.41e-04	45	75	3	CID000004628
Drug	Boldine [476-70-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	MLX DUSP6 SNAPC4 TFAP4 SPINK5	4.44e-04	193	75	5	4122_UP
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A	TBC1D5 BIRC3 RIPOR1 ZC3H7B PML	4.44e-04	193	75	5	7364_DN
Drug	retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A	NYNRIN RIPOR1 SNAPC4 SRRM2 TMEM40	4.54e-04	194	75	5	1211_DN
Drug	Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A	BIRC3 TNFAIP1 ZC3H7B AFF4 MRTFA	4.54e-04	194	75	5	7164_UP
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A	PPFIBP1 TJAP1 NKTR MFAP3L PML	4.54e-04	194	75	5	4738_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	TJAP1 TFAP4 AFF4 MRTFA PML	4.54e-04	194	75	5	4335_DN
Drug	Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; PC3; HT_HG-U133A	MXD3 TJAP1 TNFAIP1 MRTFA PML	4.54e-04	194	75	5	5880_UP
Drug	5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA	AKAP6 MLX TBC1D5 ZFYVE26 PML	4.54e-04	194	75	5	862_UP
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	NKTR TNFAIP1 SNAPC4 ZC3H7B SPEN	4.54e-04	194	75	5	4312_DN
Drug	Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	PKP3 CEP41 TNFAIP1 ZC3H7B PML	4.54e-04	194	75	5	2793_DN
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A	FRMPD4 NYNRIN SNAPC4 AFF4 MRTFA	4.54e-04	194	75	5	4552_UP
Drug	Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A	NYNRIN CEP41 MRTFA PML SPINK5	4.54e-04	194	75	5	3284_UP
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A	NYNRIN ZC3H7B SRRM2 MRTFA PML	4.54e-04	194	75	5	4422_DN
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	TCOF1 TNFAIP1 TFAP4 AFF4 MRTFA	4.65e-04	195	75	5	4706_DN
Drug	Benzethonium chloride [121-54-0]; Up 200; 9uM; HL60; HT_HG-U133A	PPP1R26 MXD3 ANK2 PKP3 PML	4.65e-04	195	75	5	2508_UP
Drug	ST021200; Down 200; 10uM; PC3; HT_HG-U133A	MXD3 TBC1D5 TJAP1 TNFAIP1 PML	4.65e-04	195	75	5	7493_DN
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; HL60; HT_HG-U133A	AKAP6 PKP3 AFF4 PML SPINK5	4.65e-04	195	75	5	2924_UP
Drug	Leflunomide [75706-12-6]; Up 200; 14.8uM; PC3; HT_HG-U133A	TBC1D5 TNFAIP1 MRTFA MFAP3L PML	4.65e-04	195	75	5	5884_UP
Drug	Piracetam [7491-74-9]; Up 200; 28.2uM; MCF7; HT_HG-U133A	DUSP6 RIPOR1 LY9 MFAP3L SPINK5	4.65e-04	195	75	5	2861_UP
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PPFIBP1 PKP3 TNFAIP1 AFF4 MFAP3L	4.65e-04	195	75	5	3457_DN
Drug	Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A	MXD3 ZFHX4 NKTR MFAP3L PML	4.65e-04	195	75	5	4971_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A	SNAPC4 ZC3H7B MRTFA PML SPINK5	4.65e-04	195	75	5	4433_DN
Drug	Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	MXD3 TBC1D5 RIPOR1 ZC3H7B MFAP3L	4.65e-04	195	75	5	7468_UP
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A	TJAP1 AFF4 MRTFA MFAP3L PML	4.65e-04	195	75	5	4399_DN
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	DUSP6 TJAP1 SPEN MFAP3L PML	4.65e-04	195	75	5	2884_DN
Drug	rotenone; Up 200; 1uM; MCF7; HT_HG-U133A	REEP2 AFF4 TMEM40 MRTFA PML	4.65e-04	195	75	5	5943_UP
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A	MXD3 DUSP6 SRRM2 MRTFA PML	4.76e-04	196	75	5	2382_DN
Drug	Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A	MXD3 NINL NKTR ZC3H7B TFAP4	4.76e-04	196	75	5	7419_DN
Drug	Betazole hydrochloride; Down 200; 27uM; HL60; HT_HG-U133A	TCOF1 SCRIB SNAPC4 TFAP4 PML	4.76e-04	196	75	5	1854_DN
Drug	Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A	MXD3 SNAPC4 TFAP4 MRTFA MADD	4.76e-04	196	75	5	6344_UP
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; HL60; HT_HG-U133A	MXD3 TJAP1 NKTR MRTFA PML	4.76e-04	196	75	5	2335_UP
Drug	Edrophonium chloride [116-38-1]; Down 200; 19.8uM; HL60; HG-U133A	TBC1D5 NKTR TNFAIP1 SRRM2 SPEN	4.76e-04	196	75	5	2019_DN
Drug	Felbinac [5728-52-9]; Down 200; 18.8uM; MCF7; HT_HG-U133A	BIRC3 RIPOR1 MADD MFAP3L PML	4.76e-04	196	75	5	5700_DN
Drug	Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; HL60; HG-U133A	SLC12A2 TNFAIP1 SNAPC4 ZC3H7B TFAP4	4.76e-04	196	75	5	1987_DN
Drug	(-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MXD3 RIPOR1 ZC3H7B SRRM2 AFF4	4.76e-04	196	75	5	982_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A	PKP3 TJAP1 ZFYVE26 ZC3H7B PML	4.76e-04	196	75	5	3248_DN
Drug	Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	AKAP6 ZFHX4 BIRC3 ZC3H7B PML	4.76e-04	196	75	5	2322_UP
Drug	Chenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A	PKP3 BIRC3 SNAPC4 AFF4 PML	4.76e-04	196	75	5	7310_UP
Drug	3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; HL60; HT_HG-U133A	WWP1 BIRC3 ZC3H7B TFAP4 MRTFA	4.76e-04	196	75	5	2941_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	PPFIBP1 TJAP1 MRTFA PML SPINK5	4.76e-04	196	75	5	2318_DN
Drug	Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A	CEP41 TJAP1 ZC3H7B SRRM2 MRTFA	4.76e-04	196	75	5	3703_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	MXD3 TBC1D5 TFAP4 TMEM40 MRTFA	4.76e-04	196	75	5	2086_UP
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A	MXD3 PPFIBP1 TBC1D5 ZFYVE26 AFF4	4.76e-04	196	75	5	1708_UP
Disease	Treacher Collins syndrome (implicated_via_orthology)	NOLC1 TCOF1	8.75e-05	6	72	2	DOID:2908 (implicated_via_orthology)
Disease	Osteitis Deformans	ZNF687 PML	2.09e-04	9	72	2	C0029401
Disease	nighttime rest measurement	MYO18A TANC1	1.57e-03	24	72	2	EFO_0007827

Protein segments in the cluster

Peptide	Gene	Start	Entry
SRSADVDSLSESSPN	ENHO	36	Q6UWT2
ADKSSDSSSPERASA	CXorf66	116	Q5JRM2
DSSSPERASAQSSTE	CXorf66	121	Q5JRM2
SRSRSQASPSEDEET	TNFAIP1	271	Q13829
SAASDPDAETTARTN	CEP41	96	Q9BYV8
LTSSDDALDAPSSSE	SPECC1L	356	Q69YQ0
LSTSDSPGDENAESS	BIRC3	346	Q13489
ASESLDPSDEEAASS	ATP8B3	1281	O60423
SSSSDSEANEPSQSA	AFF4	446	Q9UHB7
SSDSDSDSSSEDEPP	NOLC1	166	Q14978
QAPQGSRDSSSDSDS	NOLC1	461	Q14978
STSASSVPNTDDEDS	MLX	101	Q9UH92
SIAPDNRSKSESDAS	ANK2	3381	Q01484
SRTDKSSASAPDVDD	SERBP1	386	Q8NC51
DARKTNELPSDSSSS	MUC16	2356	Q8WXI7
NSLKRSDSPAADSDA	MFAP3L	291	O75121
SDSPAADSDASSLHE	MFAP3L	296	O75121
ADSLDSSGLSSERSD	MXD3	151	Q9BW11
SSGLSSERSDSDQEE	MXD3	156	Q9BW11
LASDSDAESDSRASS	MADD	816	Q8WXG6
DAESDSRASSPNSTV	MADD	821	Q8WXG6
ASSNQEEEDSPSSSE	MAGEB16	86	A2A368
SSSSSSSDEAGDPNE	NCKAP5L	296	Q9HCH0
AARSPSASITDEDSN	PPFIBP1	996	Q86W92
SQEEDSPDSFSSLDS	SPINK5	976	Q9NQ38
DPSDGDTLESLDSSS	GPATCH8	1246	Q9UKJ3
RDESASETSTPSEHS	MYO18A	146	Q92614
SDRDSLSDVPSSSEA	ILDR1	416	Q86SU0
NRKSPSHSSSSEDAD	NOL8	446	Q76FK4
DASEDSPLSSASSQA	ERMN	221	Q8TAM6
DSSSDGLSPDQTRSE	MYOCD	156	Q8IZQ8
NDAENLSSDSSLSSP	POU2F1	351	P14859
SSSSSSDNELAPFAR	OBSCN	6791	Q5VST9
NDSASTAPRSTEESL	OXR1	321	Q8N573
PREELSSSAFSDSND	DCST1	686	Q5T197
PESSSDSGNETNSSE	FRMPD4	901	Q14CM0
STDPASDDLASGDLS	ATF7IP	246	Q6VMQ6
PTSDSSSDSNLTTEE	LY9	531	Q9HBG7
SSPSLDSGDSDSEEL	EME1	6	Q96AY2
SSSDSSSDSDFEPSQ	MLLT1	381	Q03111
DSESDNSADSSLPSR	MLLT1	441	Q03111
SSSDIESDLDRDPNS	DUSP6	176	Q16828
SNSESSDDDSEEAPS	SDE2	226	Q6IQ49
AASLSASLDNDPSDS	EPB41L3	671	Q9Y2J2
EPDSESGSSSSLSDD	KBTBD6	651	Q86V97
PSSASVTELSDDADS	NYNRIN	966	Q9P2P1
SSSPRKQLSESSDDD	MAP4K1	366	Q92918
SALPSLSSDSDSDSD	REXO1	541	Q8N1G1
ASPQERSESDSSPDS	SRRM2	1551	Q9UQ35
TQRPAEDSSSSEESD	TCOF1	686	Q13428
SSSDEQTPSRDDDSQ	NKTR	1296	P30414
SSEDSDAENSSSREL	PML	561	P29590
DAENSSSRELDDSSS	PML	566	P29590
TSSSENDDRSGSSLE	TANC1	231	Q9C0D5
PGSLSDDSSSVDSND	PPP1R26	821	Q5T8A7
SEDSRPSASTVSEAE	SCRIB	521	Q14160
LPSSSEDSDDNGSLS	JADE1	6	Q6IE81
RPSDEDSSSLESAAS	NINL	81	Q9Y2I6
DSSSFDEDSSDALSP	MRTFA	111	Q969V6
SDTDASNLETPRSES	SP9	426	P0CG40
ASTTSNPDESADTDL	SMCR8	281	Q8TEV9
NEDSAASLTELSSSD	AKAP6	1681	Q13023
SRPHSAADDDTSSEL	CNGA2	36	Q16280
DSPDSEKSSRAASSL	PKP3	756	Q9Y446
TLSAPASSASSEEDL	TJAP1	396	Q5JTD0
DPDDNADRSETSSIA	ZFHX4	2846	Q86UP3
SSTNPADSRTEASED	REEP2	196	Q9BRK0
DSSSSSSDDSPARSV	SPEN	296	Q96T58
RSQSAALEPSSSADA	SAPCD2	176	Q86UD0
SEDADAPSKRHSTSD	ARHGAP23	666	Q9P227
PAASSSAEDSLSDAA	SLC12A2	146	P55011
SSSSSESNDEDQQPR	TMEM40	66	Q8WWA1
ASSSSVDSDPESTER	RIMKLB	346	Q9ULI2
AADEDSNDSPASSSS	ZNF687	311	Q8N1G0
SSSSSSSEEDEPEQA	SNAPC4	536	Q5SXM2
SNPSSSPDDDSSKDS	TBC1D5	771	Q92609
LEPDTSNSRSSSAFE	WWP1	311	Q9H0M0
LSSESSDDSSSPQLS	RIPOR1	381	Q6ZS17
DLASATEPANDSLSS	ZFYVE26	531	Q68DK2
EAPTSDTASDSEASD	TFAP4	306	Q01664
DSSRTLPSTDSLDDF	ZC3H7B	241	Q9UGR2
RAPDSLETSDSDSDS	NAF1	106	Q96HR8